BRL 43694A is a chemical compound that serves as the hydrochloride salt form of granisetron, a pharmaceutical active ingredient. It is a nitrogen-containing heterocyclic compound with amide and amine functional groups, possessing moderate lipophilicity and limited hydrogen bonding capacity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing BRL 43694A?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Alcaftadine carboxylic acid
pharmaceutical raw material
Solifenacin
pharmaceutical raw material
Sodium diethyl oxalacetate
pharmaceutical raw material
Gabexate mesylate
pharmaceutical raw material
Fadraciclib
pharmaceutical raw material
Tosufloxacin monohydrate
pharmaceutical raw material
Perindopril erbumine
pharmaceutical raw material
Cevimeline hydrochloride
pharmaceutical raw material
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;hydrochloride
QYZRTBKYBJRGJB-UHFFFAOYSA-N
CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl
Sourcing BRL 43694A?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.